Inoue T, Inoue T, Yoshida K, Yoshioka Y, Shimamoto S, Tanaka E, et al. Phase III trial of high- vs. low-dose-rate interstitial radiotherapy for early mobile tongue cancer. Int J Radiat Oncol Biol Phys. 2001;51:171–5.

Article  CAS  PubMed  Google Scholar 

Guinot JL, Santos M, Tortajada MI, Carrascosa M, Estellés E, Vendrell JB, et al. Efficacy of high-dose-rate interstitial brachytherapy in patients with oral tongue carcinoma. Brachytherapy. 2010;9:227–34.

Article  PubMed  Google Scholar 

Santos M, Guinot JL, Tortajada M, Vendrell JB, López C, Rosa A, et al. Is perioperative brachytherapy effective in carcinoma of the tongue? J Contemp Brachyther. 2022;14:23–8.

Article  Google Scholar 

Umeda M, Komatsubara H, Nishimatsu N, Yokoo S, Shibuya Y, Komori T. High-dose rate interstitial brachytherapy for stage I-II tongue cancer. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000;90:667–70.

Article  CAS  PubMed  Google Scholar 

Tsai CJ, Hofstede TM, Sturgis EM, Garden AS, Lindberg ME, Wei Q, et al. Osteoradionecrosis and radiation dose to the mandible in patients with oropharyngeal cancer. Int J Radiat Oncol Biol Phys. 2013;85:415–20.

Article  PubMed  Google Scholar 

Mazeron JJ, Ardiet JM, Haie-Méder C, Kovács G, Levendag P, Peiffert D, et al. GEC-ESTRO recommendations for brachytherapy for head and neck squamous cell carcinomas. Radiother Oncol. 2009;91:150–6.

Article  PubMed  Google Scholar 

Murakami S, Verdonschot RG, Kakimoto N, Sumida I, Fujiwara M, Ogawa K, et al. Preventing complications from high-dose rate brachytherapy when treating mobile tongue cancer via the application of a modular lead-lined spacer. PLoS One. 2016;11: e0154226.

Article  PubMed  PubMed Central  Google Scholar 

Rivard MJ, Coursey BM, DeWerd LA, Hanson WF, Huq MS, Ibbott GS, et al. Update of AAPM task group No. 43 report: a revised AAPM protocol for brachytherapy dose calculations. Med Phys. 2004;31:633–74.

Article  PubMed  Google Scholar 

Rivard MJ, Butler WM, DeWerd LA, Huq MS, Ibbott GS, Meigooni AS, et al. Supplement to the 2004 update of the AAPM task group No. 43 report. Med Phys. 2007;34:2187–205.

Article  PubMed  Google Scholar 

Rivard MJ, Ballester F, Butler WM, DeWerd LA, Ibbott GS, Meigooni AS, et al. Supplement 2 for the 2004 update of the AAPM Task Group No. 43 Report: Joint recommendations by the AAPM and GEC-ESTRO. Med Phys. 2017;44:e297–338.

Article  PubMed  Google Scholar 

Beaulieu L, Carlsson Tedgren A, Carrier JF, Davis SD, Mourtada F, Rivard MJ, et al. Report of the Task Group 186 on model-based dose calculation methods in brachytherapy beyond the TG-43 formalism: current status and recommendations for clinical implementation. Med Phys. 2012;39:6208–36.

Article  PubMed  Google Scholar 

Akiyama H, Yoshida K, Takenaka T, Kotsuma T, Masui K, Monzen H, et al. Effect of a lead block on alveolar bone protection in image-guided high-dose-rate interstitial brachytherapy for tongue cancer: using model-based dose calculation algorithms to correct for inhomogeneity. J Contemp Brachyther. 2022;14:87–95.

Article  Google Scholar 

Choi CH, Park SY, Park JM, Wu HG, Kim JH, Kim JI. Comparison of the IPSA and HIPO algorithms for interstitial tongue high-dose-rate brachytherapy. PLoS One. 2018;13: e0205229.

Article  PubMed  PubMed Central  Google Scholar 

Akiyama H, Yoshida K, Yamazaki H, Takenaka T, Kotsuma T, Masui K, et al. High-dose-rate interstitial brachytherapy for mobile tongue cancer: preliminary results of a dose reduction trial. J Contemp Brachyther. 2014;6:10–4.

Article  Google Scholar 

Granero D, Vijande J, Ballester F, Rivard MJ. Dosimetry revisited for the HDR 192Ir brachytherapy source model mHDR-v2. Med Phys. 2011;38:487–94.

Article  CAS  PubMed  Google Scholar 

Sato T, Iwamoto Y, Hashimoto S, Ogawa T, Furuta T, Abe S-I, et al. Features of particle and heavy ion transport code system (PHITS) version 3.02. J Nucl Sci Technol. 2018;55:684–90.

Article  CAS  Google Scholar 

Sumida I, Shiomi H, Yoshioka Y, Inoue T, Lessard E, Hsu IC, et al. Optimization of dose distribution for HDR brachytherapy of the prostate using attraction-repulsion model. Int J Radiat Oncol Biol Phys. 2006;64:643–9.

Article  PubMed  Google Scholar 

García-Consuegra A, Gimeno Morales M, Cambeiro M, Tagliaferri L, Kovacs G, Van Limbergen E, et al. Dose volume histogram constraints in patients with head and neck cancer treated with surgery and adjuvant HDR brachytherapy: a proposal of the head and neck and skin GEC ESTRO Working group. Radiother Oncol. 2021;154:128–34.

Article  PubMed  Google Scholar 

Obinata K, Ohmori K, Tuchiya K, Nishioka T, Shirato H, Nakamura M. Clinical study of a spacer to help prevent osteoradionecrosis resulting from brachytherapy for tongue cancer. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003;95:246–50.

Article  PubMed  Google Scholar 

Peppa V, Pappas E, Major T, Takácsi-Nagy Z, Pantelis E, Papagiannis P. On the impact of improved dosimetric accuracy on head and neck high dose rate brachytherapy. Radiother Oncol. 2016;120:92–7.

Article  PubMed  Google Scholar